RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 July 2011

On 27 May 2011, the Council of European Union (EU) adopted the Falsified Medicines Directive, which is meant to prevent falsified medicines from entering into the legal supply chain. The new directive includes substantive changes to Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) for active pharmaceutical ingredients (APIs) and excipients.

 

© 2022 Regulatory Affairs Professionals Society.